RETIFANLIMAB-DLWR: 19 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
19
Total FAERS Reports
2 (10.5%)
Deaths Reported
2
Hospitalizations
19
As Primary/Secondary Suspect
Prescription
Status
FDA Application: 761334 ·
First Report: 20200901 · Latest Report: 20231203
What Are the Most Common RETIFANLIMAB-DLWR Side Effects?
#1 Most Reported
Off label use
9 reports (47.4%)
#2 Most Reported
Death
2 reports (10.5%)
#3 Most Reported
Weight decreased
1 reports (5.3%)
All RETIFANLIMAB-DLWR Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 9 | 47.4% | 0 | 1 |
Who Reports RETIFANLIMAB-DLWR Side Effects? Age & Gender Data
Gender: 0.0% female, 100.0% male. Average age: 76.0 years. Most reports from: US. View detailed demographics →
Is RETIFANLIMAB-DLWR Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2020 | 1 | 0 | 1 |
| 2023 | 3 | 2 | 0 |
What Is RETIFANLIMAB-DLWR Used For?
| Indication | Reports |
|---|---|
| Anal squamous cell carcinoma | 5 |
Official FDA Label for RETIFANLIMAB-DLWR
Official prescribing information from the FDA-approved drug label.